Jefferson City, MO 50° View Live Radar Fri H 70° L 45° Sat H 64° L 41° Sun H 69° L 52° Weather Sponsored By:

Boston Scientific wins approval for new leg stent

Boston Scientific wins approval for new leg stent

May 17th, 2012 in News

NATICK, Mass. (AP) - Medical device maker Boston Scientific Corp. said Thursday it received U.S. approval for a new type of stent to treat blocked arteries in the legs.

The Food and Drug Administration approved the company's Epic Vascular Self-Expanding stent for iliac artery stenosis, a form of heart disease associated with insufficient blood flow in the legs. The disease can be treated with medication, surgery or a stenting procedure.

Stents are mesh-metal tubes used to prop open artery walls after they have been cleared of plaque. They are usually fed into the artery on a catheter and then squeezed into place using an expandable balloon.

In January, Boston Scientific reported nine-month results from a study showing lower adverse events in patients treated with the Epic stent than older stents.

The stent was approved and launched in Europe in 2009.

Company shares rose 1 cent Thursday to $6.10, then added more than 4 percent, or 28 cents, to $6.38 in after-hours trading after the announcement.